HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ABBISKO-B

12.930

+0.2902.29%

Volume:905.00K

Turnover:11.66M

Market Cap:8.69B

PE:286.30

High:13.030

Open:12.600

Low:12.600

Close:12.640

52wk High:19.780

52wk Low:4.700

Shares:672.00M

HK Float Shares:672.00M

Volume Ratio:0.33

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.045

ROE:6.88%

ROA:2.27%

PB:3.46

PE(LYR):286.30

PS:12.44

Loading ...

Overview Company News Filings

Abbisko Cayman (02256) Announces Monthly Return for January 2026

Bulletin Express

Assessing Abbisko Cayman (SEHK:2256) Valuation After FDA Acceptance Of Pimicotinib NDA

Simply Wall St.

Zhongtai Securities Maintains "Buy" Rating on ABBISKO-B (02256), Notes Progress of ABSK021 Towards Approval in China and US

BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDA

Abbisko Tumor Treatment Pimicotinib Accepted for U.S. Review

MT Newswires Live

ABBISKO-B (02256) Announces FDA Acceptance of Bejema® NDA for TGCT Treatment

Abbisko Cayman - Unit's New Drug Application for Colony-Stimulating Factor 1 Receptor Inhibitor Pimicotinib Formally Accepted by US FDA

THOMSON REUTERS

Abbisko Therapeutics Secures FDA Acceptance for Pimicotinib NDA

Major Breakthrough: Abbisko-B's (02256) Tenosynovial Giant Cell Tumor Drug Bejema® NDA Accepted by FDA

FDA Accepts Abbisko Cayman NDA for Pimicotinib in Tenosynovial Giant Cell Tumor

Abbisko Therapeutics Announces FDA Acceptance of the Nda for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

THOMSON REUTERS

Shenwan Hongyuan Maintains "Buy" Rating on ABBISKO-B (02256) as First Self-Developed Drug Approved for Market

Abbisko Unit Gets China Investigational New Drug Clearance for Tumor Drug

MT Newswires Live

CICC Maintains Outperform Rating on ABBISKO-B (02256) with Target Price of HK$20

BRIEF-Abbisko Cayman Says NMPA Clears IND Application For Unit's Abbisko's Absk141

ABBISKO-B (02256): NMPA Approves IND for Oral Small Molecule KRAS G12D Inhibitor ABSK141

Abbisko Cayman Ltd - Nmpa Clears Ind Application for Unit's Abbisko's Absk141

THOMSON REUTERS

Abbisko Cayman Ltd. Wins NMPA IND Clearance for KRAS G12D Inhibitor ABSK141

ABBISKO-B (02256): Pimicotinib Approval Accelerates Value Realization of "Billion-Dollar Molecule"

Abbisko Therapeutics’ Csf-1R Inhibitor Pimicotinib Approved by the China Nmpa, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02256/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"ABBISKO-B","latestPrice":12.93,"timestamp":1770624510004,"preClose":12.64,"halted":0,"volume":905000,"delay":0,"changeRate":0.022943037974683476,"floatShares":672000000,"shares":672000000,"eps":0.04516187574741482,"marketStatus":"Closed","change":0.29,"latestTime":"02-09 16:08:30","open":12.6,"high":13.03,"low":12.6,"amount":11663260,"amplitude":0.034019,"askPrice":12.99,"askSize":1000,"bidPrice":12.93,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.2514405130489835,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":5,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":12.64,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":0.333998,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":672000000,"roa":"2.27%","roe":"6.88%","lyrEps":0.045162,"volumeRatio":0.333998,"shares":672000000,"dividePrice":0,"high":13.03,"amplitude":0.034019,"preClose":12.64,"low":12.6,"week52Low":4.7,"pbRate":"3.46","psRate":"12.44","week52High":19.78,"institutionHeld":0,"latestPrice":12.93,"eps":0.04516187574741482,"divideRate":0,"volume":905000,"delay":0,"ttmEps":0.2514405130489835,"open":12.6,"prevYearClose":13.01,"prevWeekClose":12.64,"prevMonthClose":12.5,"prevQuarterClose":13.01,"fiveDayClose":12.5,"twentyDayClose":14.48,"sixtyDayClose":14.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2025-08-04","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754271000000,"name":null,"time":"","dateTimestamp":1754236800000,"actualEps":null},{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"Post Market","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"Post Market","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null},{"date":"2023-08-15","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692063000000,"name":null,"time":"","dateTimestamp":1692028800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1762272000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2026-02-06","current":51.543455,"percent":0.790807,"low":-234.512257,"twenty":-5.136266,"median":-1.517963,"eighty":53.524919,"high":254.727882,"avg":4.111702,"sd":82.68115,"marketCap":8498647464},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796},{"date":"2025-04-25","current":157.525338,"twenty":-7.035077,"median":-3.06483,"eighty":-1.297429,"marketCap":4745757129},{"date":"2025-05-02","current":164.646937,"twenty":-6.98082,"median":-3.059687,"eighty":-1.294598,"marketCap":4970852329},{"date":"2025-05-09","current":160.887021,"twenty":-6.966007,"median":-3.058035,"eighty":-1.289956,"marketCap":4891435796},{"date":"2025-05-16","current":166.920406,"twenty":-6.956944,"median":-3.054843,"eighty":-1.284736,"marketCap":5116329396},{"date":"2025-05-23","current":172.811396,"twenty":-6.918805,"median":-3.051744,"eighty":-1.280509,"marketCap":5312740129},{"date":"2025-05-30","current":194.14447,"twenty":-6.859825,"median":-3.047185,"eighty":-1.269715,"marketCap":5994823373},{"date":"2025-06-06","current":193.852557,"twenty":-6.827912,"median":-3.029734,"eighty":-1.263923,"marketCap":6001081017},{"date":"2025-06-13","current":206.909864,"twenty":-6.817054,"median":-3.027014,"eighty":-1.258681,"marketCap":6407827906},{"date":"2025-06-20","current":226.129725,"twenty":-6.80981,"median":-3.021411,"eighty":-1.253542,"marketCap":6989324733},{"date":"2025-06-27","current":219.382855,"twenty":-6.774951,"median":-3.010594,"eighty":-1.249178,"marketCap":6799778035},{"date":"2025-07-04","current":207.131321,"twenty":-6.751721,"median":-3.004715,"eighty":-1.245928,"marketCap":6420343195},{"date":"2025-07-11","current":194.227376,"twenty":-6.748553,"median":-2.997106,"eighty":-1.23779,"marketCap":6014301773},{"date":"2025-07-18","current":239.206864,"twenty":-6.742193,"median":-2.992401,"eighty":-1.233081,"marketCap":7401298850},{"date":"2025-07-25","current":223.606361,"twenty":-6.733962,"median":-2.987644,"eighty":-1.227416,"marketCap":6943764012},{"date":"2025-08-01","current":221.508288,"twenty":-6.720681,"median":-2.97652,"eighty":-1.21075,"marketCap":6836108756},{"date":"2025-08-08","current":50.470458,"twenty":-6.69485,"median":-2.968177,"eighty":-1.205206,"marketCap":8274964605},{"date":"2025-08-15","current":65.75115,"twenty":-6.664055,"median":-2.960553,"eighty":-1.200737,"marketCap":10764181600},{"date":"2025-08-22","current":69.328024,"twenty":-6.623327,"median":-2.952385,"eighty":-1.196881,"marketCap":11314163907},{"date":"2025-08-29","current":70.197956,"twenty":-6.58783,"median":-2.944688,"eighty":-1.195394,"marketCap":11510826312},{"date":"2025-09-05","current":74.741403,"twenty":-6.545813,"median":-2.931892,"eighty":-1.193197,"marketCap":12243700183},{"date":"2025-09-12","current":74.279336,"twenty":-6.493001,"median":-2.918097,"eighty":-1.190811,"marketCap":12189911275},{"date":"2025-09-19","current":71.544121,"twenty":-6.455769,"median":-2.873353,"eighty":-1.179252,"marketCap":11732705557},{"date":"2025-09-26","current":69.674923,"twenty":-6.40006,"median":-2.852194,"eighty":-1.166431,"marketCap":11396524882},{"date":"2025-10-03","current":74.307,"twenty":-6.312512,"median":-2.838066,"eighty":-1.159178,"marketCap":12183187662},{"date":"2025-10-10","current":70.431829,"twenty":-6.288573,"median":-2.801814,"eighty":-1.154706,"marketCap":11530997152},{"date":"2025-10-17","current":63.17088,"twenty":-6.157723,"median":-2.769702,"eighty":-1.141961,"marketCap":10334193949},{"date":"2025-10-24","current":58.25878,"twenty":-5.928147,"median":-2.735891,"eighty":-1.138284,"marketCap":9534083943},{"date":"2025-10-31","current":59.730926,"twenty":-5.921366,"median":-2.711752,"eighty":-1.135193,"marketCap":9789581256},{"date":"2025-11-07","current":58.126276,"twenty":-5.917138,"median":-2.68435,"eighty":-1.120838,"marketCap":9520636716},{"date":"2025-11-14","current":60.172448,"twenty":-5.914987,"median":-2.645577,"eighty":-1.113983,"marketCap":9883711845},{"date":"2025-11-21","current":53.525201,"twenty":-5.81235,"median":-2.567515,"eighty":-1.103539,"marketCap":8787762844},{"date":"2025-11-28","current":58.350437,"twenty":-5.778066,"median":-2.550052,"eighty":-1.098391,"marketCap":9614767305},{"date":"2025-12-05","current":57.842944,"twenty":-5.775395,"median":-2.509912,"eighty":-1.092946,"marketCap":9547531170},{"date":"2025-12-12","current":58.224062,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"marketCap":9628214532},{"date":"2025-12-19","current":54.679817,"twenty":-5.762384,"median":-1.913119,"eighty":-1.074189,"marketCap":9063430998},{"date":"2025-12-24","current":54.10565,"twenty":-5.686352,"median":-1.597844,"eighty":-1.065407,"marketCap":8996194863},{"date":"2026-01-02","current":52.443492,"twenty":-5.575606,"median":-1.569456,"eighty":-1.038831,"marketCap":8754144777},{"date":"2026-01-09","current":57.857956,"twenty":-5.571211,"median":-1.54358,"eighty":49.652014,"marketCap":9682003440},{"date":"2026-01-16","current":58.071036,"twenty":-5.564242,"median":-1.534833,"eighty":52.436859,"marketCap":9749239575},{"date":"2026-01-23","current":55.601293,"twenty":-5.468644,"median":-1.525941,"eighty":53.637621,"marketCap":9325651924},{"date":"2026-01-30","current":49.88128,"twenty":-5.183001,"median":-1.52299,"eighty":53.637621,"marketCap":8404516875},{"date":"2026-02-06","current":50.312337,"twenty":-5.136266,"median":-1.517963,"eighty":53.524919,"marketCap":8498647464}],"updateTime":1770619400183},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136358190","title":"Abbisko Cayman (02256) Announces Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136358190","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136358190?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:59","pubTimestamp":1770281966,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (stock code: 02256) published its Monthly Return for the period ended 31 January 2026, indicating that the authorized share capital remains at 5,000,000,000 ordinary shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2605469153","title":"Assessing Abbisko Cayman (SEHK:2256) Valuation After FDA Acceptance Of Pimicotinib NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2605469153","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605469153?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:58","pubTimestamp":1769057928,"startTime":"0","endTime":"0","summary":"Abbisko Cayman (SEHK:2256) is back in focus after the U.S. FDA formally accepted the New Drug Application for pimicotinib, its oral CSF-1R inhibitor for tenosynovial giant cell tumor, following positive Phase III MANEUVER trial results.\nSee our latest analysis for Abbisko Cayman.\nInvestors appear to be weighing the FDA’s NDA acceptance against earlier gains, with a 1-month share price return of 7.85% and year to date share price return of 9.68%, while the 1-year total shareholder return is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/assessing-abbisko-cayman-sehk2256-valuation-after-fda-accept","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/assessing-abbisko-cayman-sehk2256-valuation-after-fda-accept","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2778985437.USD","IE00BPRC5H50.USD","BK1161","02256","IE00B543WZ88.USD","DCF","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD","LU2476274308.USD"],"gpt_icon":0},{"id":"1131784055","title":"Zhongtai Securities Maintains \"Buy\" Rating on ABBISKO-B (02256), Notes Progress of ABSK021 Towards Approval in China and US","url":"https://stock-news.laohu8.com/highlight/detail?id=1131784055","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131784055?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:00","pubTimestamp":1768528835,"startTime":"0","endTime":"0","summary":"Zhongtai Securities has issued a research report maintaining a \"Buy\" rating on ABBISKO-B (02256). The company's core pharmaceutical product, ABSK021, recently received approval for marketing from the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU2778985437.USD","BK0276","IE00B5MMRT66.SGD","02256","LU2488822045.USD","BK1161","IE00BPRC5H50.USD","600918","LU2476274720.SGD"],"gpt_icon":0},{"id":"2603507783","title":"BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603507783","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603507783?lang=en_us&edition=fundamental","pubTime":"2026-01-13 18:09","pubTimestamp":1768298971,"startTime":"0","endTime":"0","summary":"BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDAJan 13  - Abbisko Cayman Ltd 2256.HK:UNIT'S NEW DRUG APPLICATION FOR COLONY-STIMULATING FACTOR 1 RECEPTOR INHIBITOR PIMICOTINIB FORMALLY ACCEPTED BY US FDAFurther company coverage: 2256.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02256","LU2488822045.USD","LU2476274720.SGD","LU2476274308.USD","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2603574757","title":"Abbisko Tumor Treatment Pimicotinib Accepted for U.S. Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2603574757","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603574757?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:47","pubTimestamp":1768279662,"startTime":"0","endTime":"0","summary":"Abbisko  said its tumor treatment pimicotinib was accepted for review in the U.S., according to a Hong Kong bourse filing Tuesday.The drug, which is also known as ABSK021, is meant to treat patients with tenosynovial giant cell tumor.Pimicotinib is licensed to Germany's Merck KGaA for worldwide commercialization.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2778985437.USD","LU2488822045.USD","BK1161","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","02256","LU2476274308.USD"],"gpt_icon":0},{"id":"1172213515","title":"ABBISKO-B (02256) Announces FDA Acceptance of Bejema® NDA for TGCT Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1172213515","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172213515?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:25","pubTimestamp":1768278354,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced on January 13, 2026, that its subsidiary, Shanghai Abbisko Biopharmaceuticals (Abbisko), declared that the New Drug Application (NDA) for its self-developed, novel, oral,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","LU2778985437.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU2476274720.SGD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2603571793","title":"Abbisko Cayman - Unit's New Drug Application for Colony-Stimulating Factor 1 Receptor Inhibitor Pimicotinib Formally Accepted by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603571793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603571793?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:07","pubTimestamp":1768277270,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","BK1161","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2603717975","title":"Abbisko Therapeutics Secures FDA Acceptance for Pimicotinib NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603717975","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603717975?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:07","pubTimestamp":1768277228,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics, Subsidiary of Abbisko Cayman Ltd., Announces FDA Acceptance of Pimicotinib NDA for TGCT Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL441P1h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU2476274720.SGD","BK1161","IE00B543WZ88.USD","LU2778985437.USD","02256","IE00BPRC5H50.USD","LU2488822045.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"1173645093","title":"Major Breakthrough: Abbisko-B's (02256) Tenosynovial Giant Cell Tumor Drug Bejema® NDA Accepted by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1173645093","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173645093?lang=en_us&edition=fundamental","pubTime":"2026-01-13 09:30","pubTimestamp":1768267837,"startTime":"0","endTime":"0","summary":"On January 13, 2026, Abbisko-B (02256) announced that the New Drug Application (NDA) for its self-developed, novel, oral, highly selective, and potent small molecule Colony-Stimulating Factor 1...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","02256","LU2488822045.USD","LU2476274720.SGD","09939","LU2476274308.USD","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1515","IE00B5MMRT66.SGD","BK1574"],"gpt_icon":0},{"id":"2603520653","title":"FDA Accepts Abbisko Cayman NDA for Pimicotinib in Tenosynovial Giant Cell Tumor","url":"https://stock-news.laohu8.com/highlight/detail?id=2603520653","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603520653?lang=en_us&edition=fundamental","pubTime":"2026-01-13 08:54","pubTimestamp":1768265682,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics Co., Ltd.  announced that the U.S. Food and Drug Administration  has formally accepted the New Drug Application  for pimicotinib  for the systemic treatment of patients with tenosynovial giant cell tumor . Pimicotinib, an orally administered, highly selective colony-stimulating factor 1 receptor  inhibitor, was developed by Abbisko Therapeutics and is licensed to Merck KGaA, Darmstadt, Germany, for worldwide commercialization. The NDA acceptance is supported by data from the Phase III MANEUVER trial, which demonstrated statistically significant improvements in objective response rate and patient-reported outcomes. Pimicotinib was previously approved in China by the National Medical Products Administration  for adult patients with symptomatic TGCT. Regulatory submissions for pimicotinib are also under review in other markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLtGq4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","IE00BPRC5H50.USD","LU2778985437.USD","BK1161","LU2476274308.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2603520682","title":"Abbisko Therapeutics Announces FDA Acceptance of the Nda for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor","url":"https://stock-news.laohu8.com/highlight/detail?id=2603520682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603520682?lang=en_us&edition=fundamental","pubTime":"2026-01-13 08:54","pubTimestamp":1768265662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUA65JRJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2476274720.SGD","IE00BPRC5H50.USD","BK1161","LU2778985437.USD","LU2476274308.USD","02256"],"gpt_icon":0},{"id":"1138826510","title":"Shenwan Hongyuan Maintains \"Buy\" Rating on ABBISKO-B (02256) as First Self-Developed Drug Approved for Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1138826510","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138826510?lang=en_us&edition=fundamental","pubTime":"2025-12-29 14:08","pubTimestamp":1766988519,"startTime":"0","endTime":"0","summary":"Shenwan Hongyuan released a research report stating that on December 22, ABBISKO-B (02256) announced that its CSF-1R inhibitor, pimitesinib, received marketing approval from China's NMPA for the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000166","02256","IE00B543WZ88.USD","LU2476274308.USD","BK0183","BK0028","IE00B5MMRT66.SGD","BK0012","LU2778985437.USD","BK0276","BK0188","IE00BPRC5H50.USD","BK1161","LU2488822045.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2593148447","title":"Abbisko Unit Gets China Investigational New Drug Clearance for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2593148447","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593148447?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:49","pubTimestamp":1766540963,"startTime":"0","endTime":"0","summary":"Abbisko  unit Abbisko Therapeutics received clearance for the investigational new drug application for ABSK141 from China's National Medical Products Administration, a Wednesday Hong Kong bourse filing said.The drug is for the treatment of patients with advanced solid tumors harboring KRAS G12D mutations.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5MMRT66.SGD","LU2476274720.SGD","BK1161","IE00B543WZ88.USD","LU2778985437.USD","02256","IE00BPRC5H50.USD","LU2488822045.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"1124484368","title":"CICC Maintains Outperform Rating on ABBISKO-B (02256) with Target Price of HK$20","url":"https://stock-news.laohu8.com/highlight/detail?id=1124484368","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124484368?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:32","pubTimestamp":1766539949,"startTime":"0","endTime":"0","summary":"CICC has reiterated its forecast for ABBISKO-B's (02256) net profit attributable to shareholders at RMB48 million for 2025 and RMB320 million for 2026. Based on the DCF model, the firm maintains an...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2778985437.USD","02256"],"gpt_icon":0},{"id":"2593644289","title":"BRIEF-Abbisko Cayman Says NMPA Clears IND Application For Unit's Abbisko's Absk141","url":"https://stock-news.laohu8.com/highlight/detail?id=2593644289","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593644289?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:01","pubTimestamp":1766538107,"startTime":"0","endTime":"0","summary":"BRIEF-Abbisko Cayman Says NMPA Clears IND Application For Unit's Abbisko's Absk141Dec 24 (Reuters) - Abbisko Cayman Ltd 2256.HK:NMPA CLEARS IND APPLICATION FOR UNIT'S ABBISKO'S ABSK141Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nFWN3XT0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","BK1161","LU2476274308.USD","02256","IE00B5MMRT66.SGD","LU2476274720.SGD","IE00B543WZ88.USD","LU2778985437.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"1136490242","title":"ABBISKO-B (02256): NMPA Approves IND for Oral Small Molecule KRAS G12D Inhibitor ABSK141","url":"https://stock-news.laohu8.com/highlight/detail?id=1136490242","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136490242?lang=en_us&edition=fundamental","pubTime":"2025-12-24 08:06","pubTimestamp":1766534819,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that its subsidiary, Shanghai Abbisko Biomedical Technology Co., Ltd., has received approval from China's National Medical Products Administration (NMPA) for the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU2778985437.USD","BK1161","IND","IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","02256","IE00B543WZ88.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2593444902","title":"Abbisko Cayman Ltd - Nmpa Clears Ind Application for Unit's Abbisko's Absk141","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444902","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593444902?lang=en_us&edition=fundamental","pubTime":"2025-12-24 08:01","pubTimestamp":1766534465,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nFWN3XT0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02256","LU2488822045.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU2476274308.USD","BK1161","IE00B5MMRT66.SGD","LU2476274720.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2593744901","title":"Abbisko Cayman Ltd. Wins NMPA IND Clearance for KRAS G12D Inhibitor ABSK141","url":"https://stock-news.laohu8.com/highlight/detail?id=2593744901","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593744901?lang=en_us&edition=fundamental","pubTime":"2025-12-24 08:00","pubTimestamp":1766534441,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited announced that its subsidiary, Abbisko Therapeutics Co., Ltd., has received clearance from the China National Medical Products Administration  for the Investigational New Drug  application of ABSK141. ABSK141 is an oral, highly potent, and selective small-molecule KRAS G12D inhibitor intended for the treatment of patients with advanced solid tumors harboring KRAS G12D mutations. The IND clearance enables the initiation of an open-label Phase I/II clinical trial to further evaluate the safety and efficacy of ABSK141. No grant or funding from other organizations was mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nNDL6q7H8B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2476274308.USD","LU2488822045.USD","IE00BPRC5H50.USD","LU2476274720.SGD","LU2778985437.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","02256"],"gpt_icon":0},{"id":"1129906585","title":"ABBISKO-B (02256): Pimicotinib Approval Accelerates Value Realization of \"Billion-Dollar Molecule\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1129906585","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129906585?lang=en_us&edition=fundamental","pubTime":"2025-12-23 09:10","pubTimestamp":1766452235,"startTime":"0","endTime":"0","summary":"This year, driven by the bullish market for innovative drugs in Hong Kong stocks, the Hang Seng Healthcare Index (800804) surged from 2,331.02 points at the beginning of the year to a yearly high of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","02256","LU2488822045.USD","LU2778985437.USD","BK1161","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2593481058","title":"Abbisko Therapeutics’ Csf-1R Inhibitor Pimicotinib Approved by the China Nmpa, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593481058?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:30","pubTimestamp":1766403002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274308.USD","BK1161","LU2476274720.SGD","LU2778985437.USD","02256","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2488822045.USD","IE00B5MMRT66.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":79,"code":"91000000","status":"200"}]}}